Development and Pilot Investigation of Behavioral Activation for Negative Symptoms
Mairs et al.
Behav Modif 2011;35:486-506.
ABSTRACT
Delta EEG Band as a Marker of Left Hypofrontality for Language in Schizophrenia Patients
Spironelli et al.
Schizophr Bull 2011;37:757-767.
ABSTRACT
| FULL TEXT
Disrupted Functional Brain Connectivity during Verbal Working Memory in Children and Adolescents with Schizophrenia
White et al.
Cereb Cortex 2011;21:510-518.
ABSTRACT
| FULL TEXT
Dissociable Contributions of Left and Right Dorsolateral Prefrontal Cortex in Planning
Kaller et al.
Cereb Cortex 2011;21:307-317.
ABSTRACT
| FULL TEXT
Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis
Daumann et al.
J Psychopharmacol 2010;24:1515-1524.
ABSTRACT
Modafinil Reverses Phencyclidine-Induced Deficits in Cognitive Flexibility, Cerebral Metabolism, and Functional Brain Connectivity
Dawson et al.
Schizophr Bull 2010;0:sbq090v1-sbq090.
ABSTRACT
| FULL TEXT
Short-term Effects of Antipsychotic Treatment on Cerebral Function in Drug-Naive First-Episode Schizophrenia Revealed by "Resting State" Functional Magnetic Resonance Imaging
Lui et al.
Arch Gen Psychiatry 2010;67:783-792.
ABSTRACT
| FULL TEXT
Positron Emission Tomography in Schizophrenia: A New Perspective
Patel et al.
JNM 2010;51:511-520.
ABSTRACT
| FULL TEXT
Auditory Oddball Deficits in Schizophrenia: An Independent Component Analysis of the fMRI Multisite Function BIRN Study
Kim et al.
Schizophr Bull 2009;35:67-81.
ABSTRACT
| FULL TEXT
Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection
Lieberman et al.
Pharmacol. Rev. 2008;60:358-403.
ABSTRACT
| FULL TEXT
Dysfunctional and Compensatory Prefrontal Cortical Systems, Genes and the Pathogenesis of Schizophrenia
Tan et al.
Cereb Cortex 2007;17:i171-i181.
ABSTRACT
| FULL TEXT
Increased Prefrontal Cerebral Blood flow in First-Episode Schizophrenia Following Treatment: Longitudinal Positron Emission Tomography Study
Brewer et al.
Aust N Z J Psychiatry 2007;41:129-135.
ABSTRACT
| FULL TEXT
Effects of {gamma}-Aminobutyric Acid-Modulating Drugs on Working Memory and Brain Function in Patients With Schizophrenia
Menzies et al.
Arch Gen Psychiatry 2007;64:156-167.
ABSTRACT
| FULL TEXT
Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function
Honey et al.
Brain 2005;128:2597-2611.
ABSTRACT
| FULL TEXT
Chromatin Alterations Associated With Down-regulated Metabolic Gene Expression in the Prefrontal Cortex of Subjects With Schizophrenia
Akbarian et al.
Arch Gen Psychiatry 2005;62:829-840.
ABSTRACT
| FULL TEXT
Partial agonism and schizophrenia
Bolonna and Kerwin
Br. J. Psychiatry 2005;186:7-10.
FULL TEXT
Rostral anterior cingulate cortex dysfunction during error processing in schizophrenia
Laurens et al.
Brain 2003;126:610-622.
ABSTRACT
| FULL TEXT
Regional Specificity in the Neuropathologic Substrates of Schizophrenia: A Morphometric Analysis of Broca's Area 44 and Area 9
Selemon et al.
Arch Gen Psychiatry 2003;60:69-77.
ABSTRACT
| FULL TEXT
Impaired Visual Object Recognition and Dorsal/Ventral Stream Interaction in Schizophrenia
Doniger et al.
Arch Gen Psychiatry 2002;59:1011-1020.
ABSTRACT
| FULL TEXT
Excessive recruitment of neural systems subserving logical reasoning in schizophrenia
Ramsey et al.
Brain 2002;125:1793-1807.
ABSTRACT
| FULL TEXT
Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia
Middleton et al.
J. Neurosci. 2002;22:2718-2729.
ABSTRACT
| FULL TEXT
Focal Gray Matter Density Changes in Schizophrenia
Hulshoff Pol et al.
Arch Gen Psychiatry 2001;58:1118-1125.
ABSTRACT
| FULL TEXT
Selective Deficits in Prefrontal Cortex Function in Medication-Naive Patients With Schizophrenia
Barch et al.
Arch Gen Psychiatry 2001;58:280-288.
ABSTRACT
| FULL TEXT
Reduced GAP-43 mRNA in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia
Weickert et al.
Cereb Cortex 2001;11:136-147.
ABSTRACT
| FULL TEXT
Physiological Dysfunction of the Dorsolateral Prefrontal Cortex in Schizophrenia Revisited
Callicott et al.
Cereb Cortex 2000;10:1078-1092.
ABSTRACT
| FULL TEXT
Repeated Assessment of the Tower of Hanoi Test: Reliability and Age Effects
Ahonniska et al.
Assessment 2000;7:297-310.
ABSTRACT
Functional Imaging of Memory Retrieval in Deficit vs Nondeficit Schizophrenia
Heckers et al.
Arch Gen Psychiatry 1999;56:1117-1123.
ABSTRACT
| FULL TEXT
A Unitary Model of Schizophrenia: Bleuler's "Fragmented Phrene" as Schizencephaly
Andreasen
Arch Gen Psychiatry 1999;56:781-787.
ABSTRACT
| FULL TEXT
Synergistic Interactions between Ampakines and Antipsychotic Drugs
Johnson et al.
J. Pharmacol. Exp. Ther. 1999;289:392-397.
ABSTRACT
| FULL TEXT
Development of the Tower of London-Revised
Schnirman et al.
Assessment 1998;5:355-360.
ABSTRACT
Cortical Dysfunction in Schizophrenia During Auditory Word and Tone Working Memory Demonstrated by Functional Magnetic Resonance Imaging
Stevens et al.
Arch Gen Psychiatry 1998;55:1097-1103.
ABSTRACT
| FULL TEXT
The Construct Validity of The Tower of London DX As a Measure of The Executive Functioning of ADHD Children
Culbertson and Zillmer
Assessment 1998;5:215-226.
ABSTRACT
S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: I. Receptorial and Neurochemical Profile in Comparison with Clozapine and Haloperidol
Millan et al.
J. Pharmacol. Exp. Ther. 1998;286:1341-1355.
ABSTRACT
| FULL TEXT
S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
Millan et al.
J. Pharmacol. Exp. Ther. 1998;286:1356-1373.
ABSTRACT
| FULL TEXT
Cerebral Blood Flow Velocity in Acute Schizophrenic Patients : A Transcranial Doppler Ultrasonography Study
Owega et al.
Stroke 1998;29:1149-1154.
ABSTRACT
| FULL TEXT
Characterization of Psychotic Conditions: Use of the Domains of Psychopathology Model
Ratakonda et al.
Arch Gen Psychiatry 1998;55:75-81.
ABSTRACT
| FULL TEXT
Measurement of Glutamate and Glutamine in the Medial Prefrontal Cortex of Never-Treated Schizophrenic Patients and Healthy Controls by Proton Magnetic Resonance Spectroscopy
Bartha et al.
Arch Gen Psychiatry 1997;54:959-965.
ABSTRACT
Rehabilitation of Frontal/Executive Impairments in Schizophrenia
Delahunty and Morice
Aust N Z J Psychiatry 1996;30:760-767.
ABSTRACT
Schizophrenic Deficits in the Processing of Context: A Test of a Theoretical Model
Servan-Schreiber et al.
Arch Gen Psychiatry 1996;53:1105-1112.
ABSTRACT
Enhanced Amphetamine Sensitivity and Increased Expression of Dopamine D2 Receptors in Postpubertal Rats after Neonatal Excitotoxic Lesions of the Medial Prefrontal Cortex
Flores et al.
J. Neurosci. 1996;16:7366-7375.
ABSTRACT
| FULL TEXT
Local and Distributed Effects of Apomorphine on Fronto-Temporal Function in Acute Unmedicated Schizophrenia
Fletcher et al.
J. Neurosci. 1996;16:7055-7062.
ABSTRACT
| FULL TEXT
Auditory Attentional Deficits in Patients With Schizophrenia: A Positron Emission Tomography Study
O'Leary et al.
Arch Gen Psychiatry 1996;53:633-641.
ABSTRACT
Brain Glucose Metabolism During Non--Rapid Eye Movement Sleep in Major Depression: A Positron Emission Tomography Study
Ho et al.
Arch Gen Psychiatry 1996;53:645-652.
ABSTRACT
What have We Learned from Functional Imaging Studies in Schizophrenia? the Role of Frontal, Striatal and Temporal Areas
Velakoulis and Pantelis
Aust N Z J Psychiatry 1996;30:195-209.
ABSTRACT
Frontal and Temporal Lobe Brain Volumes in Schizophrenia: Relationship to Symptoms and Clinical Subtype
Turetsky et al.
Arch Gen Psychiatry 1995;52:1061-1070.
ABSTRACT
Abnormally High Neuronal Density in the Schizophrenic Cortex: A Morphometric Analysis of Prefrontal Area 9 and Occipital Area 17
Selemon et al.
Arch Gen Psychiatry 1995;52:805-818.
ABSTRACT
Clozapine Treatment of Schizophrenia
Pickar and Hsiao
JAMA 1995;274:981-983.
ABSTRACT
Resting Cerebral Glucose Metabolism in First-Episode and Previously Treated Patients With Schizophrenia Relates to Clinical Features
Gur et al.
Arch Gen Psychiatry 1995;52:657-667.
ABSTRACT
A Longitudinal Study of Symptom Dimensions in Schizophrenia: Prediction and Patterns of Change
Arndt et al.
Arch Gen Psychiatry 1995;52:352-360.
ABSTRACT
An In Vivo Study of the Prefrontal Cortex of Schizophrenic Patients at Different Stages of Illness via Phosphorus Magnetic Resonance Spectroscopy
Stanley et al.
Arch Gen Psychiatry 1995;52:399-406.
ABSTRACT
Neural Circuitry of the Prefrontal Cortex in Schizophrenia
Lewis
Arch Gen Psychiatry 1995;52:269-273.
ABSTRACT
Prefrontal Cortex and Schizophrenia: A Quantitative Magnetic Resonance Imaging Study
Wible et al.
Arch Gen Psychiatry 1995;52:279-288.
ABSTRACT
Regional Brain Abnormalities in Schizophrenia Measured With Magnetic Resonance Imaging
Andreasen et al.
JAMA 1994;272:1763-1769.
ABSTRACT
Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging
Andreasen et al.
Science 1994;266:294-298.
ABSTRACT
Neuropsychological Impairments in Deficit vs Nondeficit Forms of Schizophrenia
Buchanan et al.
Arch Gen Psychiatry 1994;51:804-811.
ABSTRACT
Risk Factors for Spontaneous Dyskinesia in Schizophrenia
Fenton et al.
Arch Gen Psychiatry 1994;51:643-650.
ABSTRACT
The Neuropsychology of the Prefrontal Cortex
Rezai et al.
Arch Neurol 1993;50:636-642.
ABSTRACT
Advancing a Neurodevelopmental Origin for Schizophrenia
Bloom
Arch Gen Psychiatry 1993;50:224-227.
ABSTRACT
